Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04640259 · ClinicalTrials.gov registry record
Epidemiology of Young Lung Cancer - Survey
A clinical trial of NSCLC, sponsored by Addario Lung Cancer Medical Institute.
- Active
- Registry status
- 250
- Enrollment target
- 2
- Study locations
NCT04640259: Active study of NSCLC, sponsored by Addario Lung Cancer Medical Institute.
NCT04640259 is a study of NSCLC that is active but no longer recruiting, run by Addario Lung Cancer Medical Institute. The registered enrollment target is 250 participants, above the 220-participant average among 71 other NSCLC trials with a reported enrollment target (14% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04640259, a study of NSCLC, is active but no longer recruiting, sponsored by Addario Lung Cancer Medical Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.
Primary Outcome
Exploratory correlations between all questionnaire variables (demographic factors, medical history, smoking history, early life exposures (child and mother), residential history, occupational history, menstrual and reproductive history, diet, and physical activity.
Conditions Studied
Interventions
- OTHER Online Survey
Study Locations (2)
California
- USC Keck School of Medicine - Los Angeles
- Addario Lung Cancer Medical Institute - San Carlos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-03 |
What the registry record for NCT04640259 still lists
NCT04640259 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 220-participant average among 71 other NSCLC trials with a reported enrollment target (14% higher).
The record links to 1 condition, with NSCLC appearing as the primary indexed condition, and to 1 intervention - of which Online Survey is the first listed.
NCT04640259 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04640259 about?
NCT04640259 is a clinical study titled "Epidemiology of Young Lung Cancer - Survey". This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.
What is the current status of trial NCT04640259?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2021-02-01. Estimated completion is 2026-03.
What conditions does trial NCT04640259 study?
This clinical trial studies the following conditions: NSCLC.
What interventions are being tested in trial NCT04640259?
The interventions under investigation include: Online Survey (OTHER).
Who is sponsoring clinical trial NCT04640259?
This trial is sponsored by Addario Lung Cancer Medical Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04640259 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NSCLC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04640259's enrollment target sits among peer trials
250 20th of 71 higher than 50 of 71 other NSCLC trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NSCLC trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
RECRUITING · Phase 1
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI